In the present study, we identified five novel autoantibodies with possible diagnostic value in ACPA‐negative RA (anti‐ANAPC15, anti‐LSP1, anti‐APBB1, anti‐PTMS, and anti‐UBL7), especially in the early stage. This evidence concerns the gene UBL7 and rheumatoid arthritis.